(Q37709739)

English

Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials

scientific article published on 15 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

chemoradiotherapy

0 references

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

author name string

K Bujko

1

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

R Glynne-Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

M Bujko

3

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

publication date

15 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1743-1750

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Chemotherapy as an Adjuvant to Surgery for Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Adjuvant chemoimmuno- and immunotherapy in Dukes' stage B2 and C colorectal carcinoma: a 7-year follow-up analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS)

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Molecular analysis of Mycobacterium isolates from extrapulmonary specimens obtained from patients in Mexico

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Low rectal cancer: a call for a change of approach in abdominoperineal resection.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Serosal involvement in gastrointestinal cancer: its assessment and significance

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Oncological Outcomes After Total Mesorectal Excision for Cure for Cancer of the Lower Rectum: Anterior vs. Abdominoperineal Resection

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ054

21 January 2018

Identifiers

10.1093/ANNONC/MDQ054

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37709739&oldid=2093974721"